About Ab Initio Biotherapeutics

What does Ab Initio Biotherapeutics do?

Ab Initio Biotherapeutics is a provider of antigen discovery and antibody generation solutions using a proprietary platform targeting multi-transmembrane proteins such as GPCRs, supporting therapeutics for neurological, cardiovascular, endocrine and gastrointestinal disorders; offerings include antibody optimization, single B-cell screening of immune repertoires, the OmniAb Discovery Platform, OmniRat and OmniMouse with high-throughput screening.

Who are Ab Initio Biotherapeutics's competitors?

Ab Initio Biotherapeutics's competitors and similar companies include ImCheck Therapeutics, Circassia, CEL-SCI, Abgenix, and OncoSec.

Where is Ab Initio Biotherapeutics headquartered?

Ab Initio Biotherapeutics is headquartered in United States.

How many employees does Ab Initio Biotherapeutics have?

Ab Initio Biotherapeutics has 1,000 employees 🔒.

When was Ab Initio Biotherapeutics founded?

Ab Initio Biotherapeutics was founded in 2010 🔒.

What sector and industry vertical is Ab Initio Biotherapeutics in?

Ab Initio Biotherapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Ab Initio Biotherapeutics

Who are the top strategic acquirers in Ab Initio Biotherapeutics's sector and industry

Top strategic M&A buyers and acquirers in Ab Initio Biotherapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Ab Initio Biotherapeutics?

Top strategic M&A buyers groups and sectors for Ab Initio Biotherapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Ab Initio Biotherapeutics's sector and industry vertical

Which are the top PE firms investing in Ab Initio Biotherapeutics's sector and industry vertical?

Top PE firms investing in Ab Initio Biotherapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Ab Initio Biotherapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Ab Initio Biotherapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Ab Initio Biotherapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Ab Initio Biotherapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Ab Initio Biotherapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Ab Initio Biotherapeutics?

The key public trading comparables and valuation benchmarks for Ab Initio Biotherapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Ab Initio Biotherapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Ab Initio Biotherapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Ab Initio Biotherapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Ab Initio Biotherapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Ab Initio Biotherapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Ab Initio Biotherapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.